[Therapeutic effect on hemophilia by AMCHA].
D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000032:analysis; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005169:Factor VIII / Q000032:analysis; D006467:Hemophilia A / Q000188:drug therapy*; D002836:Hemophilia B / Q000188:drug therapy; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010919:Placebos; D013916:Thrombelastography
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D003509:Cyclohexanecarboxylic Acids; D010919:Placebos; D005169:Factor VIII; D007611:Aprotinin
Therapeutische Beinflussung der Hämophilie durch AMCHA.